Latest Breaking News On - Bridgebio pharma daily - Page 4 : comparemela.com

Jennison Associates LLC Has $781,000 Position in BridgeBio Pharma, Inc (NASDAQ:BBIO)

Jennison Associates LLC trimmed its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 4.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 19,357 shares of the company’s stock after selling 944 shares during the quarter. Jennison Associates LLC’s holdings in BridgeBio Pharma were worth $781,000 at the end of […]

Sakhalinskaya oblastRandalw scottBio pharmaBio pharma incJennison associates llc bio pharmaXponance incBridgebio pharma incAssetmark incJennison associatesCantor fitzgeraldHoldings channelHealthcare of ontario pension plan trust fundChina universal asset management coJpmorgan chase coBridgebio pharmaFree report

Duality Advisers LP Has $3 24 Million Stake in BridgeBio Pharma, Inc (NASDAQ:BBIO)

Duality Advisers LP Has $3 24 Million Stake in BridgeBio Pharma, Inc (NASDAQ:BBIO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRandalw scottBio pharmaKokusai asset management coBridgebio pharma incCantor fitzgeraldBio pharma incHoldings channelMitsubishi ufjJpmorgan chase coMirae asset global investments coDuality advisersBridgebio pharmaFree reportState retirement systemAsset management

Duality Advisers LP Buys 31,036 Shares of BridgeBio Pharma, Inc (NASDAQ:BBIO)

Duality Advisers LP Buys 31,036 Shares of BridgeBio Pharma, Inc (NASDAQ:BBIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesRandalw scottBio pharmaChina universal asset management coXponance incJpmorgan chase coBio pharma incSecurities exchange commissionHealthcare of ontario pension plan trust fundAssetmark incCantor fitzgeraldExchange commissionBridgebio pharma incDuality advisersBridgebio pharmaFree report

Moody Aldrich Partners LLC Sells 12,528 Shares of BridgeBio Pharma, Inc (NASDAQ:BBIO)

Moody Aldrich Partners LLC decreased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 124,984 shares of the company’s stock after selling 12,528 shares during the period. Moody Aldrich Partners LLC owned about 0.07% […]

Randalw scottRaymond jamesBio pharmaBridgebio pharmaHannah valantineMoody aldrich partnersAssetmark incQuantamental technologiesBridgebio pharma incJpmorgan chase coAnalysts bio pharma incBio pharma incFree reportAldrich partnersStreet marketsInvestment management

BridgeBio Pharma, Inc (NASDAQ:BBIO) Shares Sold by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 124,984 shares of the company’s stock after selling 12,528 shares during the period. Moody Aldrich Partners LLC’s holdings in BridgeBio Pharma were worth $5,046,000 as of […]

Handelsinvest investeringsforvaltningRandalw scottBridgebio pharmaRaymond jamesBio pharmaHannah valantineMoody aldrich partners llc bio pharmaBio pharma incRaymond james associatesJpmorgan chase coSecurities exchange commissionCantor fitzgeraldMirae asset global investments coBridgebio pharma incChina universal asset management coMoody aldrich partners